A peptide template as an allosteric supramolecular catalyst for the cleavage of phosphate esters.
The heptapeptide H-Iva-Api-Iva-ATANP-Iva-Api-Iva-NHCH(3) (P1a), where Iva is (S)-isovaline, Api is 4-amino-4-carboxypiperidine, and ATANP is (S)-2-amino-3-[1-(1,4,7-triazacyclononane)]propanoic acid, has been synthesized. Its conformation in aqueous solution is essentially that of a 3(10)-helix. By connecting three copies of P1a to a functionalized Tris(2-aminoethyl)amine (Tren) platform a new peptide template, [T(P1)(3)], was obtained. This molecule is able to bind up to four metal ions (Cu(II) or Zn(II)): one in the Tren subsite and three in the azacyclononane subunits. The binding of the metals to the Tren platform induces a change from an open to a closed conformation in which the three short, helical peptides are aligned in a parallel manner with the azacyclonane units pointing inward within the pseudocavity they define. T(P1)(3) shows a peculiar behavior in the transphosphorylation of phosphate esters; the tetrazinc complex is a catalyst of the cleavage of 2-hydroxypropyl-p-nitrophenyl phosphate (HPNP), whereas the free ligand is a catalyst of the cleavage of an oligomeric RNA sequence with selectivity for pyrimidine bases. In the case of HPNP, Zn(II) acts as a positive allosteric effector by enhancing the catalytic efficiency of the system. In the case of the polyanionic RNA substrate, Zn(II) switches off the activity, thus behaving as a negative allosteric regulator. It is suggested that the opposite behavior of the catalyst induced by Zn(II) is associated with the change of conformation of the Tren platform, and consequently of the relative spatial disposition of the three linked peptides, that occurs after binding of the metal ion.
Scarso
Alessandro
A
University of Padova, Department of Organic Chemistry and Consiglio Nazionale delle Ricerche-Centro Meccanismi Reazioni Organiche, 35131 Padova, Italy.
Scheffer
Ute
U
Göbel
Michael
M
Broxterman
Quirinus B
QB
Kaptein
Bernard
B
Formaggio
Fernando
F
Toniolo
Claudio
C
Scrimin
Paolo
P
D000495:Allosteric Site; D001665:Binding Sites; D002384:Catalysis; D002942:Circular Dichroism; D004305:Dose-Response Relationship, Drug; D004952:Esters / Q000737:chemistry*; D006868:Hydrolysis; D007700:Kinetics; D008024:Ligands; D008956:Models, Chemical; D008958:Models, Molecular; D010455:Peptides / Q000737:chemistry*; D010710:Phosphates / Q000737:chemistry*; D011485:Protein Binding; D011487:Protein Conformation; D012313:RNA / Q000737:chemistry / Q000378:metabolism; D015032:Zinc / Q000737:chemistry
D004952:Esters; D008024:Ligands; D010455:Peptides; D010710:Phosphates; D012313:RNA; D015032:Zinc